These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 17448192

  • 1. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma.
    Perna AG, Ostler DA, Ivan D, Lazar AJ, Diwan AH, Prieto VG, Reed JA.
    J Cutan Pathol; 2007 May; 34(5):381-5. PubMed ID: 17448192
    [Abstract] [Full Text] [Related]

  • 2. CD10 is expressed in cutaneous clear cell lesions of different histogenesis.
    Perna AG, Smith MJ, Krishnan B, Reed JA.
    J Cutan Pathol; 2005 May; 32(5):348-51. PubMed ID: 15811119
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y, Izumi M, Yoshioka K, Ohori M, Yonou H, Tachibana M.
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
    Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED.
    Cancer; 2005 Nov 15; 104(10):2084-91. PubMed ID: 16208700
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
    Ozolek JA, Bastacky SI, Myers EN, Hunt JL.
    Laryngoscope; 2005 Jun 15; 115(6):1097-100. PubMed ID: 15933529
    [Abstract] [Full Text] [Related]

  • 10. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.
    Am J Surg Pathol; 2007 Oct 15; 31(10):1528-33. PubMed ID: 17895753
    [Abstract] [Full Text] [Related]

  • 11. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA, Tölle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, Gaspert A, Johannsen M, Jung K, Kristiansen G.
    Eur Urol; 2009 Mar 15; 55(3):669-78. PubMed ID: 18450365
    [Abstract] [Full Text] [Related]

  • 12. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
    Browning L, Bailey D, Parker A.
    J Clin Pathol; 2008 Mar 15; 61(3):293-6. PubMed ID: 17660332
    [Abstract] [Full Text] [Related]

  • 13. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
    Wang KL, Weinrach DM, Luan C, Han M, Lin F, Teh BT, Yang XJ.
    Hum Pathol; 2007 Feb 15; 38(2):239-46. PubMed ID: 17056094
    [Abstract] [Full Text] [Related]

  • 14. Expression of two isozymes of acyl-coenzyme A: cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma.
    Matsumoto K, Fujiwara Y, Nagai R, Yoshida M, Ueda S.
    Int J Urol; 2008 Feb 15; 15(2):166-70. PubMed ID: 18269457
    [Abstract] [Full Text] [Related]

  • 15. CD70: a new tumor specific biomarker for renal cell carcinoma.
    Junker K, Hindermann W, von Eggeling F, Diegmann J, Haessler K, Schubert J.
    J Urol; 2005 Jun 15; 173(6):2150-3. PubMed ID: 15879877
    [Abstract] [Full Text] [Related]

  • 16. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases.
    Ostler DA, Prieto VG, Reed JA, Deavers MT, Lazar AJ, Ivan D.
    Mod Pathol; 2010 Apr 15; 23(4):567-73. PubMed ID: 20118912
    [Abstract] [Full Text] [Related]

  • 17. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
    Yakirevich E, Morris DJ, Tavares R, Meitner PA, Lechpammer M, Noble L, de Rodriguez AF, Gomez-Sanchez CE, Wang LJ, Sabo E, Delellis RA, Resnick MB.
    Am J Surg Pathol; 2008 Jun 15; 32(6):874-83. PubMed ID: 18408592
    [Abstract] [Full Text] [Related]

  • 18. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
    Fritzsche FR, Oelrich B, Johannsen M, Kristiansen I, Moch H, Jung K, Kristiansen G.
    Clin Cancer Res; 2008 Nov 01; 14(21):7035-42. PubMed ID: 18981000
    [Abstract] [Full Text] [Related]

  • 19. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
    Cameron RI, Ashe P, O'Rourke DM, Foster H, McCluggage WG.
    Int J Gynecol Pathol; 2003 Jul 01; 22(3):272-6. PubMed ID: 12819395
    [Abstract] [Full Text] [Related]

  • 20. Characterization of HLA-G expression in renal cell carcinoma.
    Li BL, Lin A, Zhang XJ, Zhang X, Zhang JG, Wang Q, Zhou WJ, Chen HX, Wang TJ, Yan WH.
    Tissue Antigens; 2009 Sep 01; 74(3):213-21. PubMed ID: 19531101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.